AlphaHunt
Healthcare

BIIB Stock Analysis

Biogen Inc. · current price $198.04 (-0.25% today)

★★★★★ Top Tier 75/ Alpha Score
Top-tier setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
LAST EARNINGS Biogen Inc. (BIIB)

Latest earnings

EPS
$5.47 vs $3.88 est · +0.4% vs estimate BEAT
Revenue
$2.48B · -6.3% YoY
Stock reaction (1M)
+3.6%
Beat streak
4 of last 4 quarters

Key metrics

Alpha Score
75/100
Grade
A
Rev Growth YoY
+1.9%
30-day Momentum
+3.6%
Forward P/E
21.4×
Analyst Target
$220.13
Implied Upside
+9.8%

Latest news on BIIB

Similar stocks in Healthcare

WST LLY WAT MRNA DGX HOLX

View all Healthcare stocks →

BIIB — frequently asked

What is BIIB's Alpha Score?

Biogen Inc. (BIIB) currently has a TickerMover Alpha Score of 75/100, rated ★★★★★ Top Tier. The Alpha Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Biogen Inc. (BIIB) a buy?

TickerMover does not give buy or sell recommendations. BIIB scores 75/100 (★★★★★ Top Tier) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is BIIB's score updated?

BIIB's Alpha Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF, peer comparison and more — free during beta.

Open dashboard for BIIB →
TickerMover is a research tool, not financial advice. Alpha Score is a composite signal — always do your own research before investing.
Last updated automatically every 5 minutes during US market hours.
Questions? support@tickermover.com